Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Company Formed to Develop Cancer Cell Therapies

The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells. . . . → Read More: Company Formed to Develop Cancer Cell Therapies

Institute, Company Studying Neuro Disease Proteins

The Montreal Neurological Institute and Thermo Fisher Scientific are beginning a study of 30 proteins implicated in neurodegenerative diseases to validate related antibodies and reagents for advancing treatments. . . . → Read More: Institute, Company Studying Neuro Disease Proteins

Biotech Sponsoring Microbiome-Cancer Research

A biotechnology enterprise is starting research collaborations with cancer labs in the U.S. and Germany to study interactions of gut microbes on responses of individuals to cancer immunotherapies. . . . → Read More: Biotech Sponsoring Microbiome-Cancer Research

Trials Test Antibodies to Prevent Hospital Infections

Clinical trials are underway in the U.S. as part of a larger international project testing synthetic antibodies designed to prevent infections from bacteria often found in hospitals and clinics. . . . → Read More: Trials Test Antibodies to Prevent Hospital Infections

Coalition Standardizes Chronic Kidney Disease Tests

A group of medical lab companies, medical centers, and not-for-profit groups developed standardized testing protocols for chronic kidney disease, which participants expect will help more people diagnose the condition earlier. . . . → Read More: Coalition Standardizes Chronic Kidney Disease Tests

Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal

Voyager Therapeutics, a developer of gene therapies for neurological disorders, is collaborating with drug maker AbbVie on treatments for diseases resulting from the build-up of damaging proteins in the brain, as in Alzheimer’s disease. . . . → Read More: Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal

Gut Tissue From Stem Cells Simulated on Organ Chips

Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients. . . . → Read More: Gut Tissue From Stem Cells Simulated on Organ Chips

Biotechs Collaborate on Immunotherapies in $1.2B Deal

Two biotechnology companies developing cancer therapies harnessing the immune system are partnering on new treatments for solid tumor and blood-related cancers. . . . → Read More: Biotechs Collaborate on Immunotherapies in $1.2B Deal

Smart Thermometer Data Speed Flu Forecasting

Data collected from electronic thermometers are shown by researchers to track and report the spread of influenza cases in the U.S. faster than federal health authorities, as well as provide more up-to-date forecasts. . . . → Read More: Smart Thermometer Data Speed Flu Forecasting

Open-Source Discovery Seeks Neglected Disease Drug

An international online collaboration is using an open process to discover new drug compounds to treat mycetoma, a slow-progressing inflammatory fungal disease occurring mainly in developing regions, which up to now is largely neglected. . . . → Read More: Open-Source Discovery Seeks Neglected Disease Drug